Decades Later, Henrietta Lacks’ Family Wins Ethical Victory Against Pharma Giant

More than 70 years after her cells were taken without consent, Henrietta Lacks is finally seeing a measure of justice. The Lacks family has reached a settlement with pharmaceutical giant Novartis over the use of her HeLa cells, one of the most important tools in modern medicine.

Lacks’ cells were originally taken in 1951 at Johns Hopkins Hospital during treatment for cervical cancer — without her knowledge or permission. For decades, her immortal cell line fueled scientific breakthroughs, from the polio vaccine to cancer therapies, IVF, gene mapping, and COVID-19 research, while Lacks’ family received no recognition or financial benefit.

The lawsuit alleged Novartis unjustly profited from products built on the HeLa cell line. While the financial terms of the settlement remain undisclosed, both the company and the family expressed satisfaction with resolving the matter outside of court.

This settlement follows a similar 2023 agreement with Thermo Fisher Scientific, and other legal actions are still pending against pharmaceutical companies.

For the Lacks family, the fight has always been about more than money. It’s about acknowledgment, ethical responsibility, and correcting historic wrongs inflicted on a Black woman whose contributions transformed medicine.

Henrietta Lacks, a mother of five from Virginia who later lived in Baltimore, died at age 31 and was buried in an unmarked grave. Her story gained national attention through Rebecca Skloot’s 2010 book, The Immortal Life of Henrietta Lacks, later adapted into an HBO film, shining a spotlight on the ethics of medical research and informed consent.

The settlement with Novartis marks another step in holding biomedical companies accountable and ensuring Henrietta Lacks’ legacy is honored — a reminder that scientific progress must never come at the expense of human rights.